Faes Farma, S.A. (LON:0K9H)

London flag London · Delayed Price · Currency is GBP · Price in EUR
5.30
+0.00 (0.08%)
At close: Feb 11, 2026
Market Cap1.44B +56.3%
Revenue (ttm)498.51M +13.3%
Net Income91.72M +7.7%
EPS0.29
Shares Outn/a
PE Ratio15.67
Forward PE18.51
Dividend0.13 (2.36%)
Ex-Dividend DateJan 8, 2026
Volume699
Average Volume8,157
Open5.32
Previous Close5.30
Day's Range5.24 - 5.35
52-Week Range3.27 - 5.48
Beta0.25
RSI65.04
Earnings DateFeb 26, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. The company also engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, sec... [Read more]

Industry Pharmaceutical Preparations
Founded 1933
Employees 1,894
Stock Exchange London Stock Exchange
Ticker Symbol 0K9H
Full Company Profile

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.

Financial numbers in EUR Financial Statements